1-4 of 4
Veronique Fremeaux-Bacchi, MD, PhD
Close
Sort by
Journal Articles

The Global aHUS Registry: Characteristics of 826 Patients with Atypical Hemolytic Uremic Syndrome

Christoph Licht, MD FRCP(C), FASN, Gianluigi Ardissino, MD PhD, Gema Ariceta, MD PhD, David J. Cohen, MD, Christoph Gasteyger, MD, Laurence A. Greenbaum, MDPhD, Masayo Ogawa, MD FAAP, Varant Kupelian, PhD, Franz Schaefer, MD, Johan Vande Walle, MD PhD, Véronique Frémeaux-Bacchi, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4640.
https://doi.org/10.1182/blood.V126.23.4640.4640
Published: 2015
Journal Articles

Baseline Demographics and Characteristics of 466 Patients with Atypical Hemolytic Uremic Syndrome in the Global aHUS Registry

Christoph Licht, MD FRCP(C), FASN, Gianluigi Ardissino, MD PhD, Gema Ariceta, MD PhD, David Cohen, MD, Christoph Gasteyger, MD, Laurence A. Greenbaum, MDPhD, Masayo Ogawa, MD FAAP, Franz Schaefer, MD, Johan Vande Walle, MD PhD, Veronique Fremeaux-Bacchi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4204.
https://doi.org/10.1182/blood.V124.21.4204.4204
Published: 2014
Journal Articles

CH50 Activity Correlates with Residual Intravascular Hemolysis in Pts with Paroxysmal Nocturnal Hemoglobinuria Treated by Eculizumab

Regis Peffault de Latour, Veronique Fremeaux-Bacchi, MD, PhD, Raphael Porcher, PhD, Paula Rodriguez-Otero, Stephane Roncellin, Sarah Abbes, Gerard Socie
Journal: Blood
Blood (2012) 120 (21): 3193.
https://doi.org/10.1182/blood.V120.21.3193.3193
Published: 2012
Journal Articles

Efficacy of Eculizumab in a Plasmatherapy-Dependent Patient with Atypical Hemolytic Uremic Syndrome with C3 Mutation Following Plasmatherapy Withdrawal

Valerie Chatelet, MD, Veronique Fremeaux-Bacchi, MD, PhD, Maxence Ficheux, MD, Thierry Lobbedez, MD, Bruno Hurault-Deligny, MD
Journal: Blood
Blood (2008) 112 (11): 4579.
https://doi.org/10.1182/blood.V112.11.4579.4579
Published: 2008